Lymphoproliferative disorders Clinical Trials

A listing of Lymphoproliferative disorders medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Illinois

Chicago Illinois

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Chicago Illinois 60611

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Chicago Illinois 60637

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Massachusetts

Boston Massachusetts 02111

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

New York

New York New York 10065

A clinical research study of allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of Leukemia, Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific or Unspecified Childhood Solid Tumor, Protocol Specific

New York New York 10065

Patients are needed to participate in a clinical research study evaluating EBV-specific T-cells for the treatment of Non-Hodgkin's Lymphoma or Epstein-Barr Virus

Texas

Houston Texas

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Houston Texas 77030

Patients are needed to participate in a clinical research study of SGN-35

Austria

Graz 8036

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Wien 1090

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Belgium

Brussels 1200

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Brussels 1020

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Ghent 9000

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Leuven 3000

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Liège 4000

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Czech Republic

Praha 5 150 06

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Denmark

Kobenhavn O 2100

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

France

Bordeaux 33076

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Marseille cedex 5 13385

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Paris 75019

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Paris 75012

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Germany

Berlin 13353

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Duesseldorf 40225

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Essen 45122

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Frankfurt 60590

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Hamburg 20246

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

View More ▼

Jena 07740

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Kiel 24105

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Munich 80337

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Tübingen 72076

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Ulm 89075

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Würzburg 97080

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Israel

Haifa 31096

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Jerusalem 91120

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Petah Tikva 49202

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Tel Aviv 64239

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Tel Hashomer 52621

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Italy

Bologna 40138

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Genova 16147

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Monza (MB) 20900

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Napoli 80123

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Padova 35128

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

View More ▼

Roma 00161

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Roma 00165

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Japan

Nagoya-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Nagoya-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Nagoya-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Sendai-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Tokyo

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

View More ▼

Tokyo

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma